Are you worried about cognitive decline? Today's estimates are that there are nearly 50 million people in the preclinical stage of Alzheimer's. From this preclinical stage, it can take up to 20 years for a person to be diagnosed with Alzheimer's disease. It is essential to identify these individuals to allow for time for intervention to decrease the risk of developing the disease.

We now know that amyloid-beta is the attempt of the brain to clear up the inflammation. Unfortunately, if the inflammation becomes chronic, the amyloid-beta peptides become sticky and form clumps and are attached to the brain cells and later kill the brain cells. We can test for antibodies and inflammatory markers and environmental triggers that are linked to the development of Alzheimer's disease. We can test for brain proteins, growth factors, pathogens, viral infections, Lyme disease, chemicals, heavy metals, especially mercury, food cross-reactivity, and abnormalities in the blood-brain barrier and neurofilaments of the brain. Testing is essential. Knowledge is empowerment.

In addition, it's vital to know that we can now test genes that are associated with Alzheimer's. It can prevent Alzheimer's later in life. It can change the course of disease if you are already affected. We can evaluate your detoxification genes to detoxify the chemicals that were accumulated in your body and turning your autoantibodies into destroying your brain cells.

I have had several patients with memory loss, dementia, and Alzheimer's that have tested positive for Lyme. Lyme is a spirochete and can impact cerebral function in many ways. I have seen people with Lyme disease suffer from memory loss, brain infarct, palpitations, dizziness, and extreme fatigue and disorientation. Testing is essential in some cases. I am now using supportive oligonucleotide for several viral infections, as well as Lyme disease and its co-infections.

I am a member of ILADS And I am a Lyme literate M. D. I specialist in Lyme disease and it’s coinfection‘s.